Insoluble cellular prion protein and its association with prion and Alzheimer diseases

Wen-Quan Zou1, Xiaochen Zhou, Jue Yuan

  • 1Department of Pathology, National Prion Disease Pathology Surveillance Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. wenquan.zou@case.edu

Prion
|August 18, 2011
PubMed

Insights

Cellular prion protein (PrP(C)) has dual roles in cognition. Its conformation dictates whether PrP(C) is beneficial or detrimental, with insoluble PrP(C) linked to prion and Alzheimer diseases.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Prion Biology

Background:

  • Soluble cellular prion protein (PrP(C)) is known for its role in prion disease (PrD) via conversion to insoluble PrP(Sc).
  • PrP(C) also exhibits deleterious effects independent of PrP(Sc) in PrD and Alzheimer disease (AD), both impacting cognition.
  • PrP(C) has physiological functions, including involvement in cognitive processes.

Purpose of the Study:

  • To highlight evidence of PrP involvement in beneficial and deleterious pathways affecting cognition.
  • To hypothesize that PrP(C)'s conformation determines its beneficial or detrimental effects.
  • To propose that insoluble PrP(C) (iPrP(C)) is associated with PrD and AD.

Main Methods:

  • Identification of an insoluble PrP(C) conformer (iPrP(C)) in uninfected brains.
  • Comparison of iPrP(C) immunoreactivity and fragmentation with PrP(Sc) species in variably protease-sensitive prionopathy.
  • Observation of iPrP(C) interaction with amyloid-beta (Aβ) in AD.

Main Results:

  • An insoluble PrP(C) conformer (iPrP(C)) was identified in uninfected human and animal brains.
  • iPrP(C) shares characteristics with PrP(Sc) in variably protease-sensitive prionopathy.
  • iPrP(C) is the primary PrP species interacting with Aβ in AD.

Conclusions:

  • PrP(C)'s beneficial and deleterious effects in cognition are linked to its conformational flexibility.
  • The insoluble PrP(C) (iPrP(C)) conformer is associated with prion disease and Alzheimer disease.
  • Understanding PrP(C) conformation is crucial for deciphering its role in neurological disorders.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...